INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION

This adverse event was reported 180405 times

These drugs are most commonly taken by patients reporting INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION:

# Drug Count
0 DUPILUMAB 19713
1 ADAPALENE 16237
2 INSULIN GLARGINE 10398
3 ACETAMINOPHEN 9302
4 PREDNISONE 8960
5 INFLIXIMAB 7913
6 INFLIXIMAB-DYYB 7053
7 METHOTREXATE SODIUM 5866
8 PAIN RELIEVER 5447
9 ACETAMINOPHEN 500MG 5445
See all common drugs associated with INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION

INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 INFLIXIMAB-DYYB 7053 2.0467
1 TETRAHYDROZOLINE HYDROCHLORIDE 93 0.3163
2 ERGOCALCIFEROL 5252 0.1766
3 EPINEPHRINE HYDROCHLORIDE 79 0.1667
4 CEDAZURIDINE AND DECITABINE 142 0.1450
5 PERFLUOROHEXYLOCTANE 328 0.1411
6 BELUMOSUDIL 466 0.1386
7 BUROSUMAB 719 0.1108
8 GOLIMUMAB 1367 0.1086
9 TENAPANOR HYDROCHLORIDE 401 0.1080
See all drugs enriched for association with INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION